Tumor DNA sequencing data can be interpreted by computational methods that analyze genomic heterogeneity to infer evolutionary dynamics. A growing number of studies have used these approaches to link cancer evolution with clinical progression and response to therapy. Although the inference of tumor phylogenies is rapidly becoming standard practice in cancer genome analyses, standards for evaluating them are lacking. To address this need, we systematically assess methods for reconstructing tumor subclonality. First, we elucidate the main algorithmic problems in subclonal reconstruction and develop quantitative metrics for evaluating them. Then we simulate realistic tumor genomes that harbor all known clonal and subclonal mutation types and p...
Intra-tumor heterogeneity presents itself through the evolution of subclones during cancer progressi...
<p>Cancer research has made tremendous progress in understanding the basic biology of tumors. One of...
Abstract The vast majority of cancer next-generation sequencing data consist of bulk samples compose...
Tumor DNA sequencing data can be interpreted by computational methods that analyze genomic heterogen...
Tumor DNA sequencing data can be interpreted by computational methods that analyze genomic heterogen...
Subclonal reconstruction from bulk tumor DNA sequencing has become a pillar of cancer evolution stud...
Whole-genome sequencing can be used to estimate subclonal populations in tumours and this intra-tumo...
Tumours accumulate many somatic mutations in their lifetime. Some of these mutations, drivers, conve...
<div><p>Recent improvements in next-generation sequencing of tumor samples and the ability to identi...
During cancer development, the tumor cell population usually emerges from a single cell ancestor and...
Cancer is a genetic disease characterized by the emergence of genetically distinct populations of ce...
Tumours are composed of multiple subpopulations, each of which has its own genotype and phenotype. ...
Most cancers evolve from a single founder cell through a series of clonal expansions that are driven...
Multistage tumorigenesis is a dynamic process characterized by the accumulation of mutations. Thus, ...
Thesis advisor: Gabor MarthUnlike normal tissue cells, which contain identical copies of the same ge...
Intra-tumor heterogeneity presents itself through the evolution of subclones during cancer progressi...
<p>Cancer research has made tremendous progress in understanding the basic biology of tumors. One of...
Abstract The vast majority of cancer next-generation sequencing data consist of bulk samples compose...
Tumor DNA sequencing data can be interpreted by computational methods that analyze genomic heterogen...
Tumor DNA sequencing data can be interpreted by computational methods that analyze genomic heterogen...
Subclonal reconstruction from bulk tumor DNA sequencing has become a pillar of cancer evolution stud...
Whole-genome sequencing can be used to estimate subclonal populations in tumours and this intra-tumo...
Tumours accumulate many somatic mutations in their lifetime. Some of these mutations, drivers, conve...
<div><p>Recent improvements in next-generation sequencing of tumor samples and the ability to identi...
During cancer development, the tumor cell population usually emerges from a single cell ancestor and...
Cancer is a genetic disease characterized by the emergence of genetically distinct populations of ce...
Tumours are composed of multiple subpopulations, each of which has its own genotype and phenotype. ...
Most cancers evolve from a single founder cell through a series of clonal expansions that are driven...
Multistage tumorigenesis is a dynamic process characterized by the accumulation of mutations. Thus, ...
Thesis advisor: Gabor MarthUnlike normal tissue cells, which contain identical copies of the same ge...
Intra-tumor heterogeneity presents itself through the evolution of subclones during cancer progressi...
<p>Cancer research has made tremendous progress in understanding the basic biology of tumors. One of...
Abstract The vast majority of cancer next-generation sequencing data consist of bulk samples compose...